文献速递头颈外科咽喉与嗓音

基于MR的影像组学列线图预测喉癌颈淋巴结转移

[Radiomics nomogram of MR: a prediction of cervical lymph node metastasis in laryngeal cancer].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2020-01-01

该回顾性队列纳入117例接受开放手术及颈淋巴清扫的喉癌患者,按约3∶1分为训练集89例和测试集28例。基于增强T1和T2WI提取影像组学特征并降维建立标签,联合MR淋巴结状态构建列线图。训练集AUC、特异性、敏感性分别为0.930、0.930、0.875,测试集分别为0.883、0.889、0.800,DCA显示有临床获益。

要点

  • 基于MR的影像组学列线图可术前预测喉癌颈淋巴结转移。
  • 模型纳入21个影像组学特征和MR报告的淋巴结状态。
  • 训练集AUC 0.930,测试集AUC 0.883,校准良好。

核心结论

  • 基于MR的影像组学列线图对喉癌患者术前颈淋巴结转移具有良好的预测效能,具有潜在临床应用价值。

研究设计与样本

  • 回顾性队列研究,纳入2016年1月至2019年12月117例接受开放式手术并颈淋巴清扫的喉癌患者,随机分为训练集89例和测试集28例。

主要发现

  • 经降维后剩余21个影像组学特征,联合MR淋巴结状态建立列线图模型。
  • 训练集中列线图模型AUC、特异性、敏感性分别为0.930、0.930、0.875。
  • 测试集中AUC、特异性、敏感性分别为0.883、0.889、0.800。
  • ROC曲线和校准曲线均显示良好预测效能,DCA显示一定临床获益。

关键数值与推荐

  • 影像组学标签由21个特征构成,列线图纳入MR报告的淋巴结状态。

临床怎么用

  • 该模型可用于喉癌患者术前预测颈淋巴结转移,辅助临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To establish and validate a radiomics nomogram based on MR for predicting cervical lymph node metastasis in laryngeal cancer. Methods: One hundred and seventeen patients with laryngeal cancer who underwent MR examinations and received open surgery and neck dissection between January 2016 and December 2019 were included in this study. All patients were randomly divided into a training cohort (n=89) and test cohort (n=28) using computer-generated random numbers. Clinical characteristics and MR were collected. Radiological features were extracted from the MR images. Enhanced T1 and T2WI were selected for radiomics analysis, and the volume of interest was manually segmented from the Huiyihuiying radiomics cloud platform. The variance analysis (ANOVA) and the least absolute shrinkage and selection operator (LASSO) algorithm were used to reduce the dimensionality of the radiomics features in the training cohort. Then, a radiomic signature was established. The clinical risk factors were screened by using ANOVA and multivariate logistic regression. A nomogram was generated using clinical risk factors and the radiomic signature. The calibration curve and receiver operator characteristic (ROC) curve were used to confirm the nomogram's performance in the training and test sets. The clinical usefulness of the nomogram was evaluated by decision curve analysis (DCA). Furthermore, a testing cohort was used to validate the model. Results: The radiomics signature consisted of 21 features, and the nomogram model included the radiomics signature and the MR-reported lymph node status. The model showed good calibration and discrimination. The model yielded areas under the ROC curve (AUC) in the training cohort, specificity, and sensitivity of 0.930, 0.930 and 0.875. In the test cohort, the model yielded AUC, specificity and sensitivity of 0.883, 0.889 and 0.800. DCA indicated that the nomogram model was clinically useful. Conclusion: The MR-based radiomics nomogram model may be used to predict cervical lymph node metastasis of laryngeal cancer preoperatively. MR-based radiomics could serve as a potential tool to help clinicians make an optimal clinical decision. 目的: 探讨基于MR的影像组学列线图预测喉癌颈淋巴结转移的临床价值。 方法: 采用回顾性队列研究,收集2016年1月至2019年12月117例在烟台毓璜顶医院接受开放式手术并颈淋巴清扫的喉癌患者治疗前的临床资料及MR资料,完全随机法以约3∶1比例分为训练集89例和测试集28例。放射组学云平台(汇医慧影)上手动分割增强T1和T2WI的原发肿瘤感兴趣容积,提取影像组学特征。在训练集中,使用方差分析(analysis of variance,ANOVA)与套索算法(least absolute shrinkage and selection operator,LASSO)对影像组学特征进行降维,根据各自的加权系数建立影像组学标签。单因素ANOVA和多因素Logistic回归分析,确定颈淋巴转移的高危因素。联合高危因素和影像组学标签建立列线图。采用受试者工作特征(receiver operating characteristic,ROC)曲线、校准曲线评估列线图的效能,决策曲线分析(decision curve analysis,DCA)评估列线图的临床应用价值。测试集数据用于验证模型。 结果: 经降维后剩余21个影像组学特征。纳入MR淋巴结状态及影像组学标签建立列线图模型。ROC曲线和校准曲线均显示出良好的预测效能;在训练集中,列线图模型的曲线下面积(area under curve,AUC)、特异性、敏感性分别为0.930、0.930、0.875;在测试集中,AUC、特异性、敏感性分别为0.883、0.889、0.800。DCA显示列线图预测颈部淋巴结转移有一定的临床获益。 结论: 基于MR的影像组学列线图对喉癌患者术前颈淋巴结转移具有良好的预测效能,具有潜在的临床应用价值。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Jia CL, Cao Y, Song Q, et al. [Radiomics nomogram of MR: a prediction of cervical lymph node metastasis in laryngeal cancer]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020. PMID: 33342131. doi:10.3760/cma.j.cn115330-20200719-00604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。